Enhanced effects of multiple treatment electrochemotherapy

Melanoma Research

Volumn 6, Issue 6, 1996, Pages 427-433

  Jaroszeski, M J ^b   Gilbert, R ^a   Perrott, R ^b   Heller, R ^a,b  

^a University of South Florida   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Bleomycin; Electrochemotherapy; Electropermeabilization; Electroporation; Melanoma; Multiple treatment

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; INTRATUMORAL DRUG ADMINISTRATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; COMBINED MODALITY THERAPY; ELECTRIC STIMULATION THERAPY; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 0030472109     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199612000-00004     Document Type: Article

References (26)

1. Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumours using electro chemotherapy. Cancer 1996; 77: 964-971.
2. Heller R. Treatment of cutaneous nodules using electrochemotherapy. J Florida Med Assoc 1995; 82: 147-150.
3. Glass LF, Fenske NA, Jaroszeski MJ, Perrott R, Harvey DT, Reintgen DS, et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 1996; 34: 82-86.
4. Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin J Jr, Schwab G, et al. Electrochemotherapy, a novel antitumour treatment: first clinical trial. CR Acad Sci Paris 1991; 313: 613-618.
5. Belehradek M, Domenge C, Luboinnski B, Orlowski S, Belehradek J, Mir LM. Electrochemotherapy, a new antitumour treatment: first phase I-II trial. Cancer 1993; 72: 3694-3700.
6. Domenge C, Orlowski S, Luboinski B, DeBaere T, Schwaab G, Belehradek J Jr, et al. Antitumour electrochemotherapy: new advances in the clinical protocol. Cancer 1996; 77: 956-963.
7. Zimmermann U, Pilwat G, Riemann F. Dielectric breakdown of cell membranes. Biophys J 1974; 14: 881-899.
8. Teissie J, Rols MP. An experimental evaluation of the critical potential difference inducing cell membrane electro permeabilization. Biophys J 1993; 65: 409-413.
9. Weaver JC. Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 1993; 51: 426-435.
10. Teissie J, Rols MP. Time course of electropermeabilization. In: Allen MJ, Cleary SF, Sowers AE, Shillady DD, eds. Charge and Field Effects in Biosystems: 3. Boston: Birkhauser, 1992: 285-301.
11. Heller R, Jaroszeski M, Leo-Messina J, Perrott R, Van Voorhis N, Reintgen D, et al. Treatment of B16 melanoma with the combination of electroporation and chemotherapy. Bioelectrochem Bioenerget 1995; 36: 83-87.
12. Heller R, Jaroszeski M, Perrott R, Messina J, Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 1996; 7(1), in press.
13. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27: 68-72.
14. Sersa G, Cemazar M, Miklavcic D. Antitumour effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res 1995; 55: 3450-3455.
15. Kanesada H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma. J Jpn Soc Cancer Ther 1990; 25: 2640-2648.
16. Belehradek J Jr, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammory tumours in mice. Eur J Cancer 1991; 27: 73-76.
17. Cemazar M, Miklavcic D, Vodovnik L, Jarm T, Rudolf Z, Stabuc B, et al. Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoural drug administration and changing of electrode orientation for electropermeabilization on EAT tumour model in mice. Radiol Oncol 1995; 29: 121-127.
18. Sersa G, Cemazar M, Semrov D, Miklavcic D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumours in mice. Biolectrochem Bioenerg 1996; 39: 61-66.
19. Okino M, Marumoto M, Kanesada H, Kuga K, Mohri H. Electrical impulse chemotherapy for rat solid tumours. Proc Jpn Cancer Congress 1987; 46: 420-420.
20. Okino M, Esato K. The effects of a single high voltage electrical stimulation with anticancer drug on in vivo growing malignant tumours. Jpn J Surg 1990; 20: 197-204.
21. Okino M, Tomie H, Kanesada H, Marumoto M, Morita N, Esato K, et al. Induction of tumour specific selective toxicity in electrical impulse chemotherapy - analysis of dose response curve. Oncologia 1991; 24: 71-79.
22. Okino M, Tomie H, Kanesada H, Marumoto M, Esato K, Suzuki H. Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res 1992; 83: 1095-1101.
23. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PCH, Mir LM. A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Comm 1993; 194: 938-943.
24. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J Jr, et al. Systemic antitumour effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Imunother 1995; 17: 30-38.
25. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumour treatment is imporoved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Network 1992; 3: 331-334.
26. Mir LM, Roth C, Orlowski S, et al. Potentiation of the antitumoral effect of electrochemotherapy by an immunotherapy with allogeneic cells producing interleukin-2. C R Acad Sci Paris 1992; 314: 499-504.